{
    "organizations": [],
    "uuid": "22b6655078fed7922af1ac57b9cc5702e915eae9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gtx-trial-results-in-stress-urinar/brief-gtx-trial-results-in-stress-urinary-incontinence-accepted-for-podium-presentation-at-sufu-idUSASB0C72X",
    "ord_in_thread": 0,
    "title": "BRIEF-GTx Trial Results In Stress Urinary Incontinence Accepted For Podium Presentation At SUFU",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - GTx Inc:\n* GTX PHASE 2 ENOBOSARM CLINICAL TRIAL RESULTS IN STRESS URINARY INCONTINENCE ACCEPTED FOR PODIUM PRESENTATION AT SUFU Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T05:47:00.000+02:00",
    "crawled": "2018-02-23T15:34:35.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "gtx",
        "inc",
        "gtx",
        "phase",
        "enobosarm",
        "clinical",
        "trial",
        "result",
        "stress",
        "urinary",
        "incontinence",
        "accepted",
        "podium",
        "presentation",
        "sufu",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}